Verv) is a genetic medicines company pioneering a new approach to the care of cardiovascular disease, transforming treatment from chronic management to. Their forecasts range from $50.00 to $92.00.
Verve therapeutics inc stock price forecast for further price development up to 6.55% (time horizon:
Verve therapeutics stock prediction. Get the latest verve therapeutics, inc. (nasdaq:verv) shares, rose in value on wednesday, 11/24/21, with the stock price up by 1.94% to the previous day’s close as strong business analysts predict comsovereign holding corp. And has now fallen 8 days in a row.
2, 2021 when the stock price was at 32.94$. Buy or sell verve therapeutics stock? Verve therapeutics (verv) stock price prediction is 36.320967610993 usd.
Verve therapeutics currently has 2 hold ratings and 3 buy ratings from wall street analysts. 1 day) and price target of 47.42 usd. Weaker technical forecast for verve therapeutics, inc.
This suggests a possible upside of 72.4% from the stock's current price. Get the latest verve therapeutics detailed stock quotes, stock trade data, stock price info, and performance analysis, including verve stock investment advice, charts, stats and more. View the latest ratings for verv.
Please note that any opinions, estimates or forecasts regarding verve therapeutics's performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of. Barron’s reported on 11/12/21 that gene editor verve unveils second wa As stock downgraded to sell candidate.
The biotech stock, which was as low as $41.52 a share on monday, climbed as high as $48.39 by thursday. Verve therapeutics inc () stock market info recommendations: The average verve therapeutics stock price prediction forecasts a potential downside of n/a from the current verv share price of $41.28.
Verve therapeutics is followed by the analysts listed above. The average price target for verv by institutional analysts is $. As of 2021 november 25, thursday current price of docs stock is 59.430$ and our data indicates that the asset price has been in an uptrend for the past 1 year (or since its inception).
The company traded as low as $30.89 and last traded at $31.41. Insiders wellington management and casdin capital and new investor fidelity have indicated an interest in purchasing up to an aggregate $75 million. During the day the stock fluctuated 4.56% from a day low at $47.35 to a day high of $49.51.
On average, wall street analysts predict that. Verve therapeutics's share price could stay at $66.67 by sep 24, 2022. Wall street stock market & finance report, prediction for the future:
Verve therapeutics is selling for under 33.15 as of the 28th of november 2021; The stock's lowest day price was 33.15. Verve therapeutics inc stock price forecast, verv predictons for2021.
Verve therapeutics started at hold with $58 stock price target at stifel nicolaus. The stock has a consensus analyst rating of buy. a buy rating indicates that analysts believe verv will outperform the market and that investors should add to their positions of verve therapeutics. On june 21, 2021, we completed our ipo in which we issued and sold an aggregate of 16,141,157 shares of our common stock, including 2,105,368 shares of common stock sold pursuant to the underwriters' full exercise of their option to purchase additional shares, at a public offering price of $19.00 per share, for aggregate net proceeds of $281.6.
(nasdaq:verv)s stock price dropped 5.7% on thursday. Approximately 9,162 shares changed hands during trading, a decline of 98% from the average daily volume of 401,011 shares. About verve therapeutics verve therapeutics, inc.
24, 2021 at 8:00 a.m. Verv) is up 16.5% for the week. You'll find the verve therapeutics share forecasts, stock quote and buy / sell signals below.according to present data verve therapeutics's verv shares and potentially its market environment have been in a bullish cycle in the.
Verv investment & stock information. In the medium term (3months), verv's stock price should underperform the. On average, they anticipate verve therapeutics' stock price to reach $71.20 in the next year.
Verv stock forecast our latest prediction for verve therapeutics inc's stock price was made on the dec. Verve therapeutics inc (verv) stock price prediction by analysts. The verve therapeutics stock forecast is 36.320967610993 usd for 2022 december 02,.
According to the issued ratings of 5 analysts in the last year, the consensus rating for verve therapeutics stock is buy based on the current 2 hold ratings and 3 buy ratings for verv. The average price target for verv set by the institutional analysts is $73.78 where high estimate is $88.20, median $76.5 and low $58.58.
0 komentar:
Posting Komentar